Sign in
4

Changes in Ownership

Camp4 Therapeutics Corp Filed Acc 0001628280-26-042860

Options or other derivatives

  • Director acquired 28,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Holtzman Steven H · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-10 Grant or award : show line 1 in the form Stock Option (Right to Buy) +28,000 28,000 D
Loading xslF345X06/wk-form4_1781295354.xml…